Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)

McGill University

$120,000.00

Multimodal, multi-omics brain biological age and its association with cognition and multiple sclerosis

EF 2025-26

Résumé
Aging drives a decline in physiological function, contributing to chronic disease onset and progression. In multiple sclerosis (MS), disability correlates strongly with chronological age, independent of disease duration. Chronological age, however, fails to capture inter-individual differences in biological aging, motivating the development of biological age measures. Biological age can be estimated using multiomic approaches-including proteomics, metabolomics, and telomere length-as well as organ-specific models such as MRI-based brain age. The brain is a key target due to its central role in age-related pathology and MS. The biological age gap (BAG)-the difference between chronological and biological age-may serve as a marker of cognitive decline and disease outcomes in MS. We will develop multimodal biological age clocks using UK Biobank MRI (n=62,000), proteomics (n=50,000), and metabolomics (n=120,000) data. CNS-enriched proteins and metabolites will be prioritized, and machine learning approaches including LASSO, Ridge regression, and Boruta with gradient boosting (LightGBM) will predict chronological age. Preliminary analyses show correlations of 0.67-0.86 and mean absolute errors <5 years. Using the Canadian Longitudinal Study on Aging (CLSA; MRI n=2630, metabolomics n=8299), we will assess the association of BAG with memory, executive function, and verbal fluency over 15 years using Cox and logistic models. In our longitudinal MS cohort (>1,200 patients, 14,243 visits, >3,300 MRI scans), we will evaluate BAG as a biomarker for progression, relapse, and treatment response, integrating MRI, proteomics, and telomere data. Preliminary work confirms MS lesions do not prevent accurate brain age estimation. This project aims to stratify patients by biological age, identify those at risk, and enable precision medicine in MS and other age-related disorders.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
560181
Name
mejia garcia alejandro
Region
Qu&eacute;bec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Multimodal, multi-omics brain biological age and its association with cognition and multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Aging; Machine Learning; Metabolomics; Mri; Multiple Sclerosis; Proteomics
Abstract
Aging drives a decline in physiological function, contributing to chronic disease onset and progression. In multiple sclerosis (MS), disability correlates strongly with chronological age, independent of disease duration. Chronological age, however, fails to capture inter-individual differences in biological aging, motivating the development of biological age measures. Biological age can be estimated using multiomic approaches-including proteomics, metabolomics, and telomere length-as well as organ-specific models such as MRI-based brain age. The brain is a key target due to its central role in age-related pathology and MS. The biological age gap (BAG)-the difference between chronological and biological age-may serve as a marker of cognitive decline and disease outcomes in MS. We will develop multimodal biological age clocks using UK Biobank MRI (n=62,000), proteomics (n=50,000), and metabolomics (n=120,000) data. CNS-enriched proteins and metabolites will be prioritized, and machine learning approaches including LASSO, Ridge regression, and Boruta with gradient boosting (LightGBM) will predict chronological age. Preliminary analyses show correlations of 0.67-0.86 and mean absolute errors <5 years. Using the Canadian Longitudinal Study on Aging (CLSA; MRI n=2630, metabolomics n=8299), we will assess the association of BAG with memory, executive function, and verbal fluency over 15 years using Cox and logistic models. In our longitudinal MS cohort (>1,200 patients, 14,243 visits, >3,300 MRI scans), we will evaluate BAG as a biomarker for progression, relapse, and treatment response, integrating MRI, proteomics, and telomere data. Preliminary work confirms MS lesions do not prevent accurate brain age estimation. This project aims to stratify patients by biological age, identify those at risk, and enable precision medicine in MS and other age-related disorders.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
mejia garcia, alejandro
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~